INVO Fertility (IVF) Income from Discontinued Operations (2025)
INVO Fertility's (IVF) quarterly Income from Discontinued Operations came in at 541247.0 in Q2 2025.
INVO Fertility (IVF) Income from Discontinued Operations (2025) Analysis & Trends
INVO Fertility (IVF) has 1 years of Income from Discontinued Operations data on file, last reported at 541247.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | - |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | - |
| 10 | INVO Fertility | 1.52 Mn | -3.38 Mn | 732,978.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -541,247.00 |